Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
55.11
+2.34 (4.43%)
At close: Jun 26, 2026, 4:00 PM EDT
55.34
+0.23 (0.42%)
After-hours: Jun 26, 2026, 7:40 PM EDT
Spruce Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Spruce Biosciences stock have an average target of 149.71, with a low estimate of 120 and a high estimate of 230. The average target predicts an increase of 171.66% from the current stock price of 55.11.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Spruce Biosciences stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Initiates $123 | Buy | Initiates | $123 | +123.19% | Jun 16, 2026 |
| JonesTrading | JonesTrading | Buy Initiates $135 | Buy | Initiates | $135 | +144.96% | Jun 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $200 → $150 | Buy | Reiterates | $200 → $150 | +172.18% | Jun 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $283 → $230 | Buy | Reiterates | $283 → $230 | +317.35% | May 27, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $140 → $120 | Buy | Reiterates | $140 → $120 | +117.75% | May 15, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
78.19M
EPS This Year
-25.64
from -50.83
EPS Next Year
4.95
from -25.64
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 200.0M | |
| Avg | n/a | 78.2M | |
| Low | n/a | 3.4M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 19.5% |
| Avg | - | -47.7% |
| Low | - | -81.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -22.16 | 38.85 | |
| Avg | -25.64 | 4.95 | |
| Low | -33.25 | -19.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.